JP2016528236A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528236A5
JP2016528236A5 JP2016533450A JP2016533450A JP2016528236A5 JP 2016528236 A5 JP2016528236 A5 JP 2016528236A5 JP 2016533450 A JP2016533450 A JP 2016533450A JP 2016533450 A JP2016533450 A JP 2016533450A JP 2016528236 A5 JP2016528236 A5 JP 2016528236A5
Authority
JP
Japan
Prior art keywords
seq
antibody
monoclonal antibody
human
timp2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016533450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016528236A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/050195 external-priority patent/WO2015021308A1/en
Publication of JP2016528236A publication Critical patent/JP2016528236A/ja
Publication of JP2016528236A5 publication Critical patent/JP2016528236A5/ja
Pending legal-status Critical Current

Links

JP2016533450A 2013-08-07 2014-08-07 生物学的試料において改善された性能を有するtimp2のためのアッセイ Pending JP2016528236A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361863073P 2013-08-07 2013-08-07
US61/863,073 2013-08-07
PCT/US2014/050195 WO2015021308A1 (en) 2013-08-07 2014-08-07 Assays for timp2 having improved performance in biological samples

Publications (2)

Publication Number Publication Date
JP2016528236A JP2016528236A (ja) 2016-09-15
JP2016528236A5 true JP2016528236A5 (cg-RX-API-DMAC7.html) 2017-08-10

Family

ID=52461941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533450A Pending JP2016528236A (ja) 2013-08-07 2014-08-07 生物学的試料において改善された性能を有するtimp2のためのアッセイ

Country Status (12)

Country Link
US (2) US9879091B2 (cg-RX-API-DMAC7.html)
EP (2) EP3030582A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016528236A (cg-RX-API-DMAC7.html)
KR (1) KR20160039682A (cg-RX-API-DMAC7.html)
CN (1) CN105531291A (cg-RX-API-DMAC7.html)
AU (1) AU2014305883A1 (cg-RX-API-DMAC7.html)
BR (1) BR112016002685A2 (cg-RX-API-DMAC7.html)
CA (1) CA2920521A1 (cg-RX-API-DMAC7.html)
EA (1) EA201690185A1 (cg-RX-API-DMAC7.html)
HK (1) HK1222180A1 (cg-RX-API-DMAC7.html)
MX (1) MX2016001573A (cg-RX-API-DMAC7.html)
WO (1) WO2015021308A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778615B2 (en) 2008-10-21 2014-07-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ702527A (en) 2009-12-20 2016-07-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011269775B2 (en) 2010-06-23 2015-01-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
WO2015084939A1 (en) 2013-12-03 2015-06-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2016164854A1 (en) 2015-04-09 2016-10-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20170189908A1 (en) * 2015-12-30 2017-07-06 Bio-Rad Laboratories, Inc. Droplet assay system with automatic calibration
EP3465201A4 (en) 2016-06-06 2020-08-26 Astute Medical, Inc. MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
WO2018006049A1 (en) * 2016-06-30 2018-01-04 The Research Foundation For The State University Of New York Compositions and methods for modifying activity of extracellular mmp-2
WO2018081578A1 (en) * 2016-10-28 2018-05-03 Astute Medical, Inc. Use of antibodies to timp-2 for the improvement of renal function
US11346846B2 (en) 2017-02-06 2022-05-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2018187453A1 (en) * 2017-04-05 2018-10-11 Astute Medical, Inc. Assays for timp2 having improved performance in biological samples
US11435364B2 (en) 2018-05-24 2022-09-06 Renibus Therapeutics, Inc. Methods of treating patients at risk for renal injury and renal failure

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US459004A (en) 1891-09-08 Box for steaming cops
DE3029579C2 (de) 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5698671A (en) * 1989-03-21 1997-12-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metalloproteinase peptides
US5413923A (en) 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5166051A (en) 1990-08-08 1992-11-24 Genesis Labs, Inc. Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
CA2107899A1 (en) 1991-04-10 1992-10-11 Gunars Edwin Valkirs Novel conjugates and assays for simultaneous detection of multiple ligands
US6797492B2 (en) 1991-05-17 2004-09-28 Merck & Co., Inc. Method for reducing the immunogenicity of antibody variable domains
CA2103059C (en) 1991-06-14 2005-03-22 Paul J. Carter Method for making humanized antibodies
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6391265B1 (en) 1996-08-26 2002-05-21 Biosite Diagnostics, Inc. Devices incorporating filters for filtering fluid samples
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
US6045899A (en) 1996-12-12 2000-04-04 Usf Filtration & Separations Group, Inc. Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
AU8489698A (en) * 1997-07-16 1999-02-10 Charm Sciences, Inc. A test device and method for detecting the presence of a residue analyte in a sample
AU3185199A (en) * 1998-03-16 1999-10-11 Quidel Corporation Immunoassay device and method
US7214542B2 (en) * 2003-01-30 2007-05-08 Michael Hutchinson Method of processing assay test results
WO2004096832A2 (en) 2003-04-29 2004-11-11 Children's Medical Center Corporation Novel antiangiogenic peptides
WO2005015217A1 (ja) * 2003-08-11 2005-02-17 Kyowa Medex Co., Ltd. 測定対象物測定器具、測定装置および測定方法
CA2574417C (en) 2004-07-28 2010-09-28 F. Hoffmann-La Roche Ag Timp-2 as target/marker of beta cell failure
US7485468B2 (en) * 2004-10-15 2009-02-03 Galapagos Bv Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
WO2007048102A2 (en) * 2005-10-18 2007-04-26 The Government Of The United States, As Represented By The Secretary Of Health And Human Services Angio-inhibitory peptides derived from human timp-2
US8778615B2 (en) 2008-10-21 2014-07-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8900881B2 (en) * 2008-12-30 2014-12-02 Jin Po Lee Quantitative analyte assay device and method
NZ702527A (en) 2009-12-20 2016-07-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN103069277B (zh) * 2010-03-31 2016-03-30 积水医疗株式会社 利用免疫色谱法的测定法、免疫色谱测试条和用于免疫色谱法的测定试剂盒

Similar Documents

Publication Publication Date Title
JP2016528236A5 (cg-RX-API-DMAC7.html)
Wu et al. Portable GMR handheld platform for the detection of influenza A virus
Otieno et al. On-line protein capture on magnetic beads for ultrasensitive microfluidic immunoassays of cancer biomarkers
Park et al. A highly sensitive and selective diagnostic assay based on virus nanoparticles
Carlin et al. Anti-tau antibodies based electrochemical sensor for detection of tau protein biomarkers
Salmain et al. Piezoelectric immunosensor for direct and rapid detection of staphylococcal enterotoxin A (SEA) at the ng level
JP2019530875A5 (cg-RX-API-DMAC7.html)
US20210156857A1 (en) Immunoassay Methods Utilizing Trapping Conjugate
NZ613646A (en) Elisa for vegf
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
JP2016511417A5 (cg-RX-API-DMAC7.html)
JP2020516603A5 (cg-RX-API-DMAC7.html)
JP5938471B2 (ja) Tsh免疫アッセイ及び内在性夾雑物の存在下におけるtsh免疫アッセイを限定的な洗浄フォーマットで実施するための方法
Bong et al. Competitive immunoassay of SARS-CoV-2 using pig sera-derived anti-SARS-CoV-2 antibodies
CN103370621A (zh) 用于免疫测定的装置和方法
JP2013174612A5 (cg-RX-API-DMAC7.html)
Roman et al. Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis
Kim et al. Dual synergistic response for the electrochemical detection of H1N1 virus and viral proteins using high affinity peptide receptors
Real-Fernández et al. Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis
ATE408837T1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
JP2015529211A5 (cg-RX-API-DMAC7.html)
Manfredi et al. Piezoelectric immunosensor based on antibody recognition of immobilized open-tissue transglutaminase: An innovative perspective on diagnostic devices for celiac disease
WO2015166790A1 (ja) クレアチンキナーゼmbアイソザイムの測定方法及びそれに用いられるキット
Morin et al. Ultrasensitive detection of antibodies using a new Tus–Ter-lock immunoPCR system